A common immunopathogenesis mechanism for infectious diseases: The protein-homeostasis-system hypothesis

Infection and Chemotherapy

Volumn 47, Issue 1, 2015, Pages 12-26

  Lee, Kyung Yil ^a,b  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

Immunopathogenesis; Infectious diseases; Protein homeostasis system

Indexed keywords

BINDING PROTEIN; RECEPTOR; TOXIC SUBSTANCE;

CELL DAMAGE; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN HOMEOSTASIS; REVIEW; TARGET CELL;

EID: 84928578293     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2015.47.1.12     Document Type: Review

References (100)

1. Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008;6:509-21.
2. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2012;55:42-7.
3. Lee KY, Rhim JW, Kang JH. Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses 2011;76:64-9.
4. Ryu JU, Kim EK, Youn YS, Rhim JW, Lee KY. Outbreaks of mumps: an observational study over two decades in a single hospital in Korea. Korean J Pediatr. 2014;57:396-402.
5. Lee KY, Rhim JW, Kang JH. Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system". Yonsei Med J 2012;53:262-75.
6. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
7. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 (Suppl):245-54.
8. Sordillo PP, Helson L. Curcumin suppression of cytokine release and cytokine storm: a potential therapy for patients with Ebola and other severe viral infections. in vivo 2015;29:1-4.
9. Chaithanyaa N, Devireddy SK, Kishore-Kumar RV, Gali RS, Aneja V. Sympathetic ophthalmia: a review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:172-6.
10. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 2009;67:272-83.
11. Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: current concepts of pathogenesis (review). Int J Mol Med 2009;24:283-93.
12. Narasaraju T-, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, van Rooijen N, Chow VT. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011;179:199-210.
13. Yousefi S, Simon D, Simon HU. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol 2012;24:736-9.
14. Johann DJ Jr, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, Liotta LA. Clinical proteomics and biomarker discovery. Ann NY Acad Sci 2004;1022:295-305.
15. Kurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 2011;10:721-33.
16. Fricker LD. Neuropeptide-processing enzymes: applications for drug discovery. AAPS J 2005;7:E449-55.
17. Vaidya A, Brown JM, Williams JS. The renin-angiotensin-aldosterone system and calcium-regulatory hormones. J Hum Hypertens. 2015. [Epub ahead of print]
18. Weinstein SA, Schmidt JJ, Bernheimer AW, Smith LA. Characterization and amino acid sequences of two lethal peptides isolated from venom of Wagler's pit viper, Trimeresurus wagleri. Toxicon 1991;29:227-36.
19. Kasheverov IE, Utkin YN, Tsetlin VI. Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors. Curr Pharm Des 2009;15:2430-52.
20. Hervé JC. Therapeutic potential of peptide motifs-part V. Curr Pharm Des 2011;17:2592-3.
21. Gaspar D, Veiga AS, Castanho MA. From antimicrobial to anticancer peptides. A review. Front Microbiol 2013;4:294.
22. Walsh CM, Edinger AL. The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis. Immunol Rev 2010;236:95-109.
23. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469:323-35.
24. Perrone LA, Plowden JK, García-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008;4:e1000115.
25. Tanaka H, Honma S, Abe S, Tamura H. Effects of interleukin-2 and cyclosporin A on pathologic features in Mycoplasma pneumonia. Am J Respir Crit Care Med 1996;154:1908-12.
26. Bhatt NY, Allen JN. Update on eosinophilic lung diseases. Semin Respir Crit Care Med 2012;33:555-71.
27. Fish AJ, Herdman RC, Michael AF, Pickering RJ, Good RA. Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. II. Correlative study of light, immunofluorescent and electron microscopic findings. Am J Med 1970;48:28-39.
28. Wyatt RJ, JulianBA. IgA nephropathy. N Engl J Med 2013;368:2402-14.
29. Sandora TJ, Sectish TC. Pneumonia. In: Kliegman RM, Behrman RE, Staton BF, Schov NF, St.Geme III JW, eds. Nelson text books of pediatrics. 19th ed. Philadelphia, PA: Saunders Elsevier; 2011;1474-9.
30. Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 2012;66:995-1003.
31. Yasui S. Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011;46:378-90.
32. Poletti V, Romagnoli M, Piciucchi S, Chilosi M. Current status of idiopathic nonspecific interstitial pneumonia. Semin Respir Crit Care Med 2012;33:440-9.
33. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012;379:738-47.
34. Lahmer T, Heemann U. Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung. Autoimmun Rev 2012;12:169-73.
35. Talukdar R, Swaroop Vege S. Early management of severe acute pancreatitis. Curr Gastroenterol Rep 2011;13:123-30.
36. Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y, Takanashi J, Hirose S, Yamagata T, Yamanouchi H, Mizuguchi M. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 2012;34:337-43.
37. Hamilton D, Harris MD, Foweraker J, Gresham GA. Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection. J Clin Pathol 2004;57:208-9.
38. Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 2011;12:90-100.
39. Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012;79:1045-55.
40. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004;78:10213-20.
41. Bradford BM, Mabbott NA. Prion disease and the innate immune system. Viruses 2012;4:3389-419.
42. Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med 2009;30:154-60.
43. Benninger F, Steiner I. Steroids in bacterial meningitis: yes. J Neural Transm 2013;120:339-42.
44. Kim DH, Lee KY, Kim MS, Youn YS, Hwang JY, Rhim JW, Kang JH, Lee JS. Corticosteroid treatment in siblings affected with severe Mycoplasma pneumoniae pneumonia. Infect Chemother 2009;41:190-5.
45. Jefferson T, Doshi P. Multisystem failure: the story of anti-influenza drugs. BMJ 2014;348:g2263.
46. Rhim JW, Lee KY, Youn YS, Kang JH, Kim JC. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort study. BMC Infect Dis 2011;11:225.
47. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, Lee BC. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-8.
48. Youn YS, Lee SC, Rhim JW, Shin MS, Kang JH, Lee KY. Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: an observation study. Infect Chemother 2014;46:239-47.
49. Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH. Early corticoid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Crit Care 2011;15:413.
50. Annane D. Pro: the illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med 2011;183:1125-6.
51. McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008;168:1034-46.
52. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 2010;120:69-75.
53. Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med 2010;134:289-93.
54. Lee KY, Yeon YH, Lee BC. Kikuchi-Fujimoto disease with prolonged fever in children. Pediatrics 2004;114:e752-6.
55. Denny FW, Taylor-Robinson D, Allison AC. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol 1972;5:327-36.
56. Wyde PR, Couch RB, Mackler BF, Cate TR, Levy BM. Effects of low-and high-passage influenza virus infection in normal and nude mice. Infect Immun 1997;15:221-9.
57. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009;183:5301-10.
58. Rodríguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 2007;71:1094-104.
59. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012;24:408-16.
60. Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009;4:417-34.
61. Beutler BA. TLRs and innate immunity. Blood 2009;113: 1399-407.
62. Hirano M, Das S, Guo P, Cooper, MD. The evolution of adaptive immunity in vertebrates. Adv Immunol 2011;109: 125-57.
63. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012;30:1-22.
64. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669-92.
65. Hozumi N, Tonegawa S. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci USA 1976;73:3628-32.
66. Tonegawa S. Somatic generation of immune diversity. Biosci Rep 1988;8:3-26.
67. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, Tincani A, Doria A. Autoantibodies in lu pus: culprits or passive bystanders? Autoimmun Rev 2011;11:596-603.
68. Gut JP, Spiess C, Schmitt S, Kirn A. Rapid diagnosis of acute mumps infection by a direct immunoglobulin M antibody capture enzyme immunoassay with labeled antigen. J Clin Microbiol 1985;21:346-52.
69. Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. Comparison of mumps-IgM ELISAs in acute infection. J Clin Virol 2007;38:153-6.
70. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, Apostolou A, Blog D, Zimmerman CM, Montana B, Harpaz R, Hickman CJ, Rota PA, Rota JS, Bellini WJ, Gallagher KM. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012;367:1704-13.
71. Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, Nicolai LA, Peake L, Bellini WJ. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009;81:1819-25.
72. Lee KY, Lee HS, Hur JK, Kang JH, Lee BC. The changing epidemiology of hospitalized pediatric patients in three measles outbreaks. J Infect 2007;54:167-72.
73. Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007;356:1121-9.
74. Dudareva S, Schweiger B, Thamm M, Höhle M, Stark K, Krause G, Buda S, Haas W. Prevalence of antibodies to 2009 pandemic Influenza A (H1N1) virus in German adult population in pre-and post-pandemic period. PLoS One 2011;6:e21340.
75. Rhim JW, Go EJ, Lee KY, Youn YS, Kim MS, Park SH, Kim JC, Kang JH. Pandemic 2009 H1N1 virus infection in children and adults: A cohort study at a single hospital throughout the epidemic. Int Arch Med 2012;5:13.
76. Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 2009;158 (Suppl 1):43-50.
77. Panda S, Ding JL. Natural antibodies bridge innate and adaptive immunity. J Immunol 2015;194:13-20.
78. Lee KY, Han JW, Lee JS, Whang KT. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Paediatr 2002;91:164-7.
79. Lee KY, Lee HS, Hong JH, Han JW, Lee JS, Whang KT. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease. J Trop Pediatr 2005;51:98-101.
80. Han JW, Lee KY, Hwang JY, Koh DK, Lee JS. Antibody status in children with steroid-sensitive nephrotic syndrome. Yonsei Med J 2010;51:239-43.
81. Lee KY, Lee JS. Immunoglobulin G has a role for systemic protein modulation in vivo: a new concept of protein homeostasis. Med Hypotheses 2006;67:848-55.
82. Trowsdale J. The MHC, disease and selection. Immunol Lett 2011;137:1-8.
83. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997;18:14-7.
84. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009;85:905-10.
85. Li Z, Menoret A, Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol 2002;14:45-51.
86. Gimferrer I, Arias MT, Suárez B, Martorell J, Vives J, Lozano F. Discrepancies between serology-and sequence-based typing of HLA class I alleles among unrelated donor/recipient pairs. Transplant Proc 1999;31:2579-80.
87. Matzinger, P. The danger model: a renewed sense of self. Science 2002;296:301-5.
88. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637-50.
89. Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol 2013;39:229-46.
90. Weitz IC. Complement the hemostatic system: an intimate relationship. Thromb Res 2014;133 (Suppl 2):S117-21.
91. Ochs HD, Hitzig WH. History of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol 2012;12:577-87.
92. Liston A, Enders A, Siggs OM. Unraveling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol 2008;8:545-58.
93. Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008;225:226-43.
94. Stach CS, Herrera A, Schlievert PM. Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunol Res 2014;59:177-81.
95. Dolff S, Bijl M, Huitema MG, Limburg PC, Kallenberg CG, Abdulahad WH. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol 2011;141:197-204.
96. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011;11:375-88.
97. Mucida D, Cheroutre H. The many face-lifts of CD4 T helper cells. Adv Immunol 2010;107:139-52.
98. Macleod AS, Havran WL. Functions of skin-resident ?d T cells. Cell Mol Life Sci 2011;68:2399-408.
99. Kataru RP, Kim H, Jang C, Choi DK, Koh BI, Kim M, Gollamudi S, Kim YK, Lee SH, Koh GY. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 2011;34:96-107.
100. Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006;24:203-15.